In Vitro Characterization of a Novel Factor Xa Inhibitor, RPR 130737

This publication has 36 references indexed in Scilit:

• Patent Evaluation Cardiovascular & Renal: Novel aminoheterocyclic derivatives as inhibitors of factor Xa
  Expert Opinion on Therapeutic Patents, 1996
• Active Site–Blocked Factors VIIa and IXa Differentially Inhibit Fibrin Formation in a Human Ex Vivo Thrombosis Model
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
• Assembly of the Prothrombinase Complex Enhances the Inhibition of Bovine Factor Xa by Tick Anticoagulant Peptide
  Biochemistry, 1994
• Maintenance of canine coronary artery patency following thrombolysis with front loaded plus low dose maintenance conjunctive therapy. A comparison of factor Xa versus thrombin inhibition
  Cardiovascular Research, 1994
• Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris
  Journal of the American College of Cardiology, 1993
• The coagulation cascade: initiation, maintenance, and regulation
  Biochemistry, 1991
• Tick Anticoagulant Peptide (TAP) Is a Novel Inhibitor of Blood Coagulation Factor Xa
  Science, 1990
• Thrombin Interactions with Platelet Membrane Proteins^a
  Annals of the New York Academy of Sciences, 1986
• Protection of factor Xa from neutralization by the heparin-antithrombin complex.
  Journal of Clinical Investigation, 1983
• Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
  Biochemical Pharmacology, 1973